Coronary heart disease is still the leading cause of death worldwide. So far there was no simple and accurate test for fast detection of live threatening narrowing of the heart arteries. Cardio Explorer is the first simple AI based cardiovascular diagnostic test for current detection/exclusion of live threatening constriction of the heart arteries (reason for heart infarction). Cardio Explorer has been validated in three clinical studies and is more accurate than the often applied stress ECG. Cardio Explorer has received the Swiss Biolabs Award 2018 and the second prize at the IFAS Innovation Challenge 2018.
14.01.2020
Swiss National Startup Teams Welcomed by Chinese Ambassador After Their Roadshow to Hong Kong and China (venturelab.swiss)
15.11.2022
Selective Contract with AOK
26.04.2022
FDA Presubmission Meeting
22.02.2022
Start Reimbursement Process Germany
No Jobs
Cardio Explorer
The venture leaders - the members of the Swiss national startup team- have a clear-cut goal. They envision themselves as global players and want to take the first step to their global expansion. The ten-day business development program is specifically structured to help them achieve this goal.
Website:
www.explorishealth.com
Headquarter:
Wallisellen
Foundation Date:
October 2018
Technology:
Sectors: